BONAPH1DE

Serial Number 90667433
606

Registration Progress

Application Filed
Apr 23, 2021
Under Examination
Mar 22, 2022
Approved for Publication
Jan 25, 2022
Published for Opposition
Jan 25, 2022
Registered

Basic Information

Serial Number
90667433
Filing Date
April 23, 2021
Published for Opposition
January 25, 2022
Abandonment Date
April 24, 2023
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Apr 24, 2023
Classes
035

Rights Holder

Alnylam Pharmaceuticals, Inc.

03
Address
300 Third Street
Cambridge, MA 02142

Ownership History

Alnylam Pharmaceuticals, Inc.

Original Applicant
03
Cambridge, MA

Alnylam Pharmaceuticals, Inc.

Owner at Publication
03
Cambridge, MA

Legal Representation

Attorney
Sarah Anne Keefe

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

19 events
Date Code Type Description
Apr 24, 2023 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Apr 24, 2023 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Feb 9, 2023 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 9, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 9, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 9, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 9, 2023 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 22, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 20, 2022 EEXT I SOU TEAS EXTENSION RECEIVED
Sep 20, 2022 EXT1 S SOU EXTENSION 1 FILED
Sep 20, 2022 EX1G S SOU EXTENSION 1 GRANTED
Mar 22, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 25, 2022 PUBO A PUBLISHED FOR OPPOSITION
Jan 25, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 5, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 18, 2021 DOCK D ASSIGNED TO EXAMINER
Dec 18, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 29, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 27, 2021 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 035
Maintaining a clinical registry database for patients with inherited disorders of the liver and primary hyperoxaluria; maintaining a registry on the clinical outcomes of primary hyperoxaluria in patients over time
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Pseudo Mark
BONA FIDE; BONAFIDE

Classification

International Classes
035